Preferred Name |
Moxalactam |
|
Synonyms |
Latamoxef Ly 127935 MOXALACTAM Moxalactam Moxam |
|
Definitions |
A semisynthetic oxa-beta-lactam antibiotic, with antibacterial activity used mainly against gram-negative aerobic bacteria. Replacing the beta-lactam sulfur atom for an oxygen atom and the presence of the methyltetrazolethio moiety and the para-hydroxyphenylmalonyl group, increases the antibacterial activity of moxalactam. The 7-alpha-methoxy group and the para-hydroxyphenylmalonyl group increases the stability of this agent against beta-lactamases. The use of this agent has been associated with fatal bleeding events. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C670 |
|
CAS_Registry |
64952-97-2 |
|
CHEBI_ID |
CHEBI:599928 |
|
Chemical_Formula |
C20H20N6O9S |
|
code |
C670 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A semisynthetic oxa-beta-lactam antibiotic, with antibacterial activity used mainly against gram-negative aerobic bacteria. Replacing the beta-lactam sulfur atom for an oxygen atom and the presence of the methyltetrazolethio moiety and the para-hydroxyphenylmalonyl group, increases the antibacterial activity of moxalactam. The 7-alpha-methoxy group and the para-hydroxyphenylmalonyl group increases the stability of this agent against beta-lactamases. The use of this agent has been associated with fatal bleeding events. |
|
FDA_UNII_Code |
VUF6C936Z3 |
|
FULL_SYN |
Latamoxef Ly 127935 MOXALACTAM Moxalactam Moxam |
|
Has_Salt_Form | ||
label |
Moxalactam |
|
Legacy Concept Name |
Moxalactam |
|
NCI_Drug_Dictionary_ID |
39507 |
|
PDQ_Closed_Trial_Search_ID |
39507 |
|
PDQ_Open_Trial_Search_ID |
39507 |
|
Preferred_Name |
Moxalactam |
|
prefixIRI |
Thesaurus:C670 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance Antibiotic |
|
UMLS_CUI |
C0026651 |
|
subClassOf |